Increased oxidative stress in children with attention deficit hyperactivity disorder

References

• Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry 2007;164(6):942–8. doi:10.1176/ajp.2007.164.6.942
   PubMed Web of Science ®Google Scholar
• Willcutt EG. The prevalence of DSM-IV attention-deficit/hyperactivity disorder: a meta-analytic review. Neurotherapeutics 2012;9(3):490–9. doi:10.1007/s13311-012-0135-8
   PubMed Web of Science ®Google Scholar
• Cheng K, Myers MK. Attention deficit hyperactivity disorder. In: Stubbe ED, (ed.) Child and adolescent psychiatry. Philadelphia: Lippincott Williams & Wilkins; 2005. p. 53–73.
   Google Scholar
• Harpin VA. The effect of ADHD on the life of an individual, their family, and community from preschool to adult life. Arch Dis Child 2005;90(Suppl 1):2–7. doi:10.1136/adc.2004.059006
   PubMed Web of Science ®Google Scholar
• Durand-Rivera A, Alatorre-Miguel E, Zambrano-Sánchez E, Reyes-Legorreta C. Methylphenidate efficacy: immediate versus extended release at short term in Mexican children with ADHD assessed by conners scale and EEG. Neurol Res Int 2015:207801.
   PubMedGoogle Scholar
• Kandemir H, Kılıç BG, Ekinci S, Yüce M. An evaluation of the quality of life of children with attention-deficit/hyperactivity disorder (ADHD) and their families. Anadolu Psikiyatri Derg 2014;15(3):265–71.
   Google Scholar
• Kurman J, Rothschild-Yakar L, Angel R, Katz M. How good am i? Implicit and explicit self-esteem as a function of perceived parenting styles among children with ADHD. J Atten Disord 2015. doi:10.1177/1087054715569599.
   PubMedGoogle Scholar
• Takon I. Clinical use of a modified release methylphenidate in the treatment of childhood attention deficit hyperactivity disorder. Ann Gen Psychiatry 2011;10:25. doi:10.1186/1744-859X-10-25
   PubMed Web of Science ®Google Scholar
• Sharp SI, McQuillin A, Gurling HM. Genetics of attention-deficit hyperactivity disorder (ADHD). Neuropharmacology 2009;57(7–8):590–600. doi:10.1016/j.neuropharm.2009.08.011
   PubMed Web of Science ®Google Scholar
• Tripp G, Wickens JR. Neurobiology of ADHD. Neuropharmacology 2009;57(7–8):579–89. doi:10.1016/j.neuropharm.2009.07.026
   PubMed Web of Science ®Google Scholar
• Kandemir H, Erdal ME, Selek S, Ay Öİ, Karababa IF, Kandemir SB, et al. Evaluation of several micro RNA (miRNA) levels in children and adolescents with attention deficit hyperactivity disorder. Neurosci Lett 2014;580:158–62. doi:10.1016/j.neulet.2014.07.060
   PubMed Web of Science ®Google Scholar
• Young J, McKinney SB, Ross BM, Wahle KW, Boyle SP. Biomarkers of oxidative stress in schizophrenic and control subjects. Prostaglandins Leukot Essent Fatty Acids 2007;76(2):73–85. doi:10.1016/j.plefa.2006.11.003
   PubMed Web of Science ®Google Scholar
• Selek S, Herken H, Bulut M, Ceylan MF, Celik H, Savas HA, et al. Oxidative imbalance in obsessive compulsive disorder patients: a total evaluation of oxidant-antioxidant status. Prog Neuropsychopharmacol Biol Psychiatry 2008;32(2):487–91. doi:10.1016/j.pnpbp.2007.10.002
   PubMed Web of Science ®Google Scholar
• Yumru M, Savas HA, Kalenderoglu A, Bulut M, Celik H, Erel O. Oxidative imbalance in bipolar disorder subtypes: a comparative study. Prog Neuropsychopharmacol Biol Psychiatry 2009;33(6):1070–4. doi:10.1016/j.pnpbp.2009.06.005
   PubMed Web of Science ®Google Scholar
• Kodydková J, Vávrová L, Zeman M, Jirák R, Macásek J, Stanková B, et al. Antioxidative enzymes and increased oxidative stress in depressive women. Clin Biochem 2009;42(13–14):1368–74. doi:10.1016/j.clinbiochem.2009.06.006
   PubMed Web of Science ®Google Scholar
• Rose S, Melnyk S, Pavliv O, Bai S, Nick TG, Frye RE, et al. Evidence of oxidative damage and inflammation associated with low glutathione redox status in the autism brain. Transl Psychiatry 2012;2:134. doi:10.1038/tp.2012.61
   PubMed Web of Science ®Google Scholar
• Kandemir H, Abuhandan M, Aksoy N, Savik E, Kaya C. Oxidative imbalance in child and adolescent patients with obsessive compulsive disorder. J Psychiatr Res 2013;47(11):1831–4. doi:10.1016/j.jpsychires.2013.08.010
   PubMed Web of Science ®Google Scholar
• Tsaluchidu S, Cocchi M, Tonello L, Puri BK. Fatty acids and oxidative stress in psychiatric disorders. BMC Psychiatry 2008;8(Suppl 1):5. doi:10.1186/1471-244X-8-S1-S5
   PubMed Web of Science ®Google Scholar
• Spahis S, Vanasse M, Bélanger SA, Ghadirian P, Grenier E, Levy E. Lipid profile, fatty acid composition and pro- and anti-oxidant status in pediatric patients with attention-deficit/hyperactivity disorder. Prostaglandins Leukot Essent Fatty Acids 2008;79(1–2):47–53. doi:10.1016/j.plefa.2008.07.005
   PubMed Web of Science ®Google Scholar
• Oztop D, Altun H, Baskol G, Ozsoy S. Oxidative stress in children with attention deficit hyperactivity disorder. Clin Biochem 2012;45(10–11):745–8. doi:10.1016/j.clinbiochem.2012.03.027
   PubMed Web of Science ®Google Scholar
• Dvoráková M, Sivonová M, Trebatická J, Skodácek I, Waczuliková I, Muchová J, et al. The effect of polyphenolic extract from pine bark, Pycnogenol on the level of glutathione in children suffering from attention deficit hyperactivity disorder (ADHD). Redox Rep 2006;11(4):163–72. doi:10.1179/135100006X116664
   PubMed Web of Science ®Google Scholar
• Varol TF, Guvenir T, Tas G, Cakaloz B, Ormen M. Nitric oxide levels in disruptive behavioral disorder. Neuropsychobiology 2006;53(4):176–80. doi:10.1159/000093781
   PubMed Web of Science ®Google Scholar
• Bulut M, Selek S, Gergerlioglu HS, Savas HA, Yilmaz HR, Yuce M, et al. Malondialdehyde levels in adult attention-deficit hyperactivity disorder. J Psychiatry Neurosci 2007;32(6):435–8.
   PubMed Web of Science ®Google Scholar
• Selek S, Savas HA, Gergerlioglu HS, Bulut M, Yilmaz HR. Oxidative imbalance in adult attention deficit/hyperactivity disorder. Biol Psychol 2008;79(2):256–9. doi:10.1016/j.biopsycho.2008.06.005
   PubMed Web of Science ®Google Scholar
• Harel M, Aharoni A, Gaidukov L, Brumshtein B, Khersonsky O, Meged R, et al. Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymes. Nat Struct Mol Biol 2004;11(5):412–9. Epub 18 April 2004. Erratum in: Nat Struct Mol Biol 2004 Dec;11(12):1253. doi:10.1038/nsmb767
   PubMed Web of Science ®Google Scholar
• Gur M, Aslan M, Yildiz A, Demirbag R, Yilmaz R, Selek S, et al. Paraoxonase and arylesterase activities in coronary artery disease. Eur J Clin Invest 2006;36(11):779–87. doi:10.1111/j.1365-2362.2006.01727.x
   PubMed Web of Science ®Google Scholar
• Aslan M, Kosecik M, Horoz M, Selek S, Celik H, Erel O. Assessment of paraoxonase and arylesterase activities in patients with iron deficiency anemia. Atherosclerosis 2007;191(2):397–402. doi:10.1016/j.atherosclerosis.2006.04.007
   PubMed Web of Science ®Google Scholar
• Mabrouk H, Mechria H, Mechri A, Azizi I, Neffati F, Douki W, et al. Paraoxonase 1 activity and lipid profile in schizophrenic patients. Asian J Psychiatr 2014;9:36–40. doi:10.1016/j.ajp.2013.12.019
   PubMedGoogle Scholar
• Calik M, Oguz E, Sarikaya S, Kocaturk O, Koca B, Gungor HE, et al. An evaluation of serum paraoxonase together with arylesterase activities and oxidative stress in children with intractable epilepsy: a cross-sectional study. Epilepsy Res 2014;108(9):1591–6. doi:10.1016/j.eplepsyres.2014.08.007
   PubMed Web of Science ®Google Scholar
• Gunay S, Savran C, Aksoy UM, Maner F, Turgay A, Yargic I. The norm study, transliteral equivalence, validity, reliability of adult hyperactivity scale in Turkish adult population. Türkiye'de Psikiyatri 2006;98–107.
   Google Scholar
• Eckerson HW, Wyte MC, La Du BN. The human serum paraoxonase/arylesterase polymorphism. Am J Hum Genet 1983;35:1126–38.
   PubMed Web of Science ®Google Scholar
• Haagen L, Brock A. A new automated method for phenotyping arylesterase (E.C.3.1.1.2.) based upon inhibition of enzymatic hydrolysis of 4-nitrophenyl acetate by phenyl acetate. Eur J Clin Chem Clim Biochem 1992;30:391–5.
   PubMedGoogle Scholar
• Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 2004;37(2):112–9. doi:10.1016/j.clinbiochem.2003.10.014
   PubMed Web of Science ®Google Scholar
• Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem 2005;38(12):1103–11. doi:10.1016/j.clinbiochem.2005.08.008
   PubMed Web of Science ®Google Scholar
• Kosecik M, Erel O, Sevinc E, Selek S. Increased oxidative stress in children exposed to passive smoking. Int J Cardiol 2005;100(1):61–4. doi:10.1016/j.ijcard.2004.05.069
   PubMed Web of Science ®Google Scholar
• Archana E, Pai P, Prabhu BK, Shenoy RP, Prabhu K, Rao A. Altered biochemical parameters in saliva of pediatric attention deficit hyperactivity disorder. Neurochem Res 2012;37(2):330–4. doi:10.1007/s11064-011-0616-x
   PubMed Web of Science ®Google Scholar
• Comim CM, Gomes KM, Réus GZ, Petronilho F, Ferreira GK, Streck EL, et al. Methylphenidate treatment causes oxidative stress and alters energetic metabolism in an animal model of attention-deficit hyperactivity disorder. Acta Neuropsychiatr 2014;26(2):96–103. doi:10.1017/neu.2013.35
   PubMed Web of Science ®Google Scholar
• Martins MR, Reinke A, Petronilho FC, Gomes KM, Dal-Pizzol F, Quevedo J. Methylphenidate treatment induces oxidative stress in young rat brain. Brain Res 2006;1078(1):189–97. doi:10.1016/j.brainres.2006.01.004
   PubMed Web of Science ®Google Scholar
• Kawatani M, Tsukahara H, Mayumi M. Evaluation of oxidative stress status in children with pervasive developmental disorder and attention deficit hyperactivity disorder using urinary-specific biomarkers. Redox Rep 2011;16(1):45–6. doi:10.1179/174329211X12968219310873
   PubMed Web of Science ®Google Scholar
• Ceylan M, Sener S, Bayraktar AC, Kavutcu M. Oxidative imbalance in child and adolescent patients with attention-deficit/hyperactivity disorder. Prog Neuropsychopharmacol Biol Psychiatry 2010;34(8):1491–4. doi:10.1016/j.pnpbp.2010.08.010
   PubMed Web of Science ®Google Scholar
• Donev R, Thome J. Inflammation: good or bad for ADHD? Atten Defic Hyperact Disord 2010;2(4):257–66. doi:10.1007/s12402-010-0038-7
   PubMedGoogle Scholar
• Stoelting M, Geyer M, Reuter S, Reichelt R, Bek MJ, Pavenstädt H. Alpha/beta hydrolase 1 is upregulated in D5 dopamine receptor knockout mice and reduces O2-production of NADPH oxidase. Biochem Biophys Res Commun 2009;379(1):81–5. doi:10.1016/j.bbrc.2008.12.008
   PubMed Web of Science ®Google Scholar
• Wu J, Xiao H, Sun H, Zou L, Zhu LQ. Role of dopamine receptors in ADHD: a systematic meta-analysis. Mol Neurobiol 2012;45(3):605–20. doi:10.1007/s12035-012-8278-5
   PubMed Web of Science ®Google Scholar
• Wiecek M, Maciejczyk M, Szymura J, Szygula Z. Changes in oxidative stress and acid–base balance in men and women following maximal-intensity physical exercise. Physiol Res 2015;64(1):93–102.
   PubMed Web of Science ®Google Scholar